XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenue $ 521,334 $ 502,260 $ 486,483
Operating expenses:      
Cost of revenue, excluding depreciation and amortization of intangible assets 118,628 122,946 125,626
Research and development 222,833 216,355 194,869
Selling, general and administrative 233,403 217,402 199,921
Depreciation expense 16,645 20,501 22,584
Amortization expense 57,752 62,209 105,311
Goodwill impairment   604,555  
Impairment of long-lived assets 1,710 7,724  
Total operating expenses 650,971 1,251,692 648,311
Operating loss (129,637) (749,432) (161,828)
Other (expense) income, net (9) 1,815 1,590
Loss before taxes (129,646) (747,617) (160,238)
Provision for income taxes 10,042 13,589 18,840
Net loss (139,688) (761,206) (179,078)
Less: net loss attributable to noncontrolling interest (3,075) (3,722) (3,456)
Net loss attributable to the Company $ (136,613) $ (757,484) $ (175,622)
Loss per share attributable to the Company:      
Basic loss per share $ (3.18) $ (18.02) $ (4.18)
Diluted loss per share $ (3.18) $ (18.02) $ (4.18)
Weighted-average number of shares used in net loss per share calculations - basic 43,012 42,029 42,024
Weighted-average number of shares used in net loss per share calculations - diluted 43,012 42,029 42,024